With $354,826 in CMTA funding, the SENSE Trial is an HSN1 clinical trial investigating a potential treatment for hereditary sensory neuropathy type 1, with active participation now complete and final data analysis underway.
Simply CMT
More From Simply CMT
-
CMTA Camp Footprint Launches Fellowship with ACA Grant
A new year-long program helps campers bring the confidence of camp home
-
Walking With CMT: How Strength, Movement, and Sensation Work Together to Improve Stability
For people living with CMT, changes in muscle strength, joint motion, and sensory feedback can make walking feel less stable over time.